A1 Refereed original research article in a scientific journal

Development of anti-immunocomplex specific antibodies and non-competitive time-resolved fluorescence immunoassay for the detection of estradiol




AuthorsLeivo J., Kivimäki L., Juntunen E., Pettersson K., Lamminmäki U.

PublisherSpringer Verlag

Publication year2019

JournalAnalytical and Bioanalytical Chemistry

Journal name in sourceAnalytical and Bioanalytical Chemistry

Volume411

Issue22

First page 5633

Last page5639

Number of pages7

ISSN1618-2642

DOIhttps://doi.org/10.1007/s00216-019-01952-6

Web address https://link.springer.com/article/10.1007/s00216-019-01952-6

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/41655115


Abstract

Detection of circulatory estradiol has widespread use in various clinical applications. Particularly, the use of estradiol-specific antibodies in immunoassays is routinely used, mainly due to the cost efficiency and simplicity of the sample handling process. However, the circulatory levels of estradiol can be extremely low in some conditions, and beyond the current detection limit of existing competitive immunoassays. We describe the generation of anti-immunocomplex specific antibodies derived from synthetic antibody repertoire and the development of high-performance non-competitive immunoassay for the detection of estradiol. Phage display selections were used to isolate new antibodies from synthetic antibody library with the use of existing estradiol specific Fab fragment. The found antibodies were consecutively used to set up a time-resolved fluorescence-based immunoassay (TRFIA), which can be used to detect estradiol with exceptional sensitivity and specificity. The limit of detection and EC50 were shown to be 3.0 pg mL−1 and 32.4 pg mL−1 respectively.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 17:05